Our company was invited to attend the 2026 Taiwan–U.S. Health Industry Investment Seminar, jointly organized by the American Institute in Taiwan (AIT) and the Biotech and Pharmaceutical Industry Promotion Office (BPIPO) of Taiwan’s Ministry of Economic Affairs. The seminar was held on January 29, 2026, in Taipei.
The event focused on investment opportunities and market entry strategies for Taiwan’s health technology and biotech industries in the United States, bringing together U.S. state representatives, regulatory and tax experts, and executives with firsthand experience in U.S. expansion.
Our company took part in the seminar discussions, sharing insights from our work in the health technology sector and engaging with international partners to explore future collaboration and global growth opportunities.
The seminar provided a valuable opportunity to strengthen Singular Wings Medical’s international presence and contribute to cross-border innovation within the global health ecosystem.
